Ouro Medicines

Ouro Medicines is an immune reset company that directly addresses chronic immune-mediated diseases by combining scientific expertise, a proven track record of advancing cell-depleting therapies through clinical trials, and a robust pipeline. Ouro's leading candidate product is OM336, a BCMA-targeted bispecific TCE recently licensed from Connaught Biologics.